Chemotherapy of leprosy for control programmes : report of a WHO study group [meeting held in Geneva from 12 to 16 October 1981]
Material type:
TextSeries: World Health Organization technical report series ; no. 675Publication details: Geneva : World Health Organization, 1982.Description: 33 pISBN: - 9241206756
- QV 259
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Books
|
WHO HQ READING-RM | HQ SERIAL (Browse shelf(Opens below)) | 1 | Available | 00009284 | ||
|
Books
|
WHO HQ BORROWABLE-COLL-STACKS | QV 259 82WH (Browse shelf(Opens below)) | 2 | Withdrawn | 00009285 | ||
|
Books
|
WHO HQ ONLINE-IRIS | QV 259 82WH (Browse shelf(Opens below)) | 3 | Available | O9241206756 | ||
|
Books
|
WHO HQ READING-RM | QV 259 82WH ARA (Browse shelf(Opens below)) | 1 | Available | 00027315 | ||
|
Books
|
WHO HQ ONLINE-IRIS | QV 259 82WH ARA (Browse shelf(Opens below)) | 2 | Available | O9241206756ARA | ||
|
Books
|
WHO HQ ONLINE-IRIS | HQ SERIAL RUS (Browse shelf(Opens below)) | 1 | Available | O9241206756RUS |
Browsing WHO HQ shelves, Shelving location: READING-RM Close shelf browser (Hides shelf browser)
| QV 256 2005SU-1 Sensibilité de Plasmodium falciparum aux médicaments antipaludiques : | QV 256 2007AS Assessment of the safety of artemisinin compounds in pregnancy : | QV 256 87SC Primaquine : | QV 259 82WH ARA Chemotherapy of leprosy for control programmes : | QV 259 84WH POR Quimioterapia de lepra para programas de controle : | QV 268 91WH WHO model prescribing information : | QV 268 91WH CHI WHO model prescribing information : |
Issued in Portuguese as: Publicação científica / Organização Pan-Americana da Saúde ; no. 465.
Russian version of nos. 658-678 bound together (barcode no. 00073789).
Proposes globally applicable regimens to treat the different groups of multibacillary patients and a further combined regimen designed for the short-term chemotherapy of paucibacillary patients. The report also recommends ways of overcoming the operational problems created by the move from dapsone monotherapy to the complexities of multidrug therapy.
ara eng fre por rus spa.
WHO monograph
4
There are no comments on this title.